You are here

Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Amgen Wants Patent Dance Redo and a Halt to Hospira’s EPOGEN Biosimilar

FDA Law Blog

Thu, 09/24/15 - 09:01 am

Tags:

Amgen, patents, Hospira, biosimilars, Epogen

2 Attractive Small Biotech Stocks That Could Become Buyout Targets

Seeking Alpha

Wed, 09/23/15 - 09:55 pm

Tags:

M&A, biotech, Conatus Pharmaceuticals, Dynavax, Amgen, Celgene, Gilead Sciences

Amgen And Allergan Announce Positive Top-line Results From Phase 3 Study of Biosimilar Candidate ABP 215

Yahoo

Wed, 09/23/15 - 09:56 am

Tags:

Amgen, Allergan, ABP 215, non-small cell lung cancer

Amgen & Regeneron: No, Clinton Tweet Won’t Kill Anti-Cholesterol Drugs

Barron's

Tue, 09/22/15 - 11:41 am

Tags:

Amgen, Regeneron, Hillary Clinton

AbbVie Not Worried About Humira Biosimilars

Bidness, ETC

Mon, 09/21/15 - 10:54 am

Tags:

AbbVie, Humira, biosimilars, Gilead, Pfizer, Novartis, Amgen

FDA Grants Priority Review for Amgen's Supplemental New Drug Application for Expanded Labeling of Kyprolis® (Carfilzomib) in Relapsed Multiple Myeloma

Yahoo

Fri, 09/18/15 - 09:17 pm

Tags:

FDA, Kyprolis, Amgen, Multiple Myeloma

An update on first-ever US biosim Zarxio 2 weeks after its debut

BioPharma Dive

Fri, 09/18/15 - 11:42 am

Tags:

Novartis, Sandoz, Zarxio, bioimilars, Amgen, Neupogen

Amgen's Acquisition Of Dezima And CETP Drug Like Pfizer's '03 Buy Of Esperion. Will History Repeat?

Forbes

Thu, 09/17/15 - 10:18 am

Tags:

Amgen, Dezima, CETP inhibitors, Pfizer, M&A, Esperion Therapeutics

Amgen to buy Dezima Pharma for $300 mln in cash

Yahoo/Reuters

Wed, 09/16/15 - 09:43 am

Tags:

Amgen, Dezima, M&A, TA-8995

Amgen, Xencor In $1.75 Billion Cancer Drug Alliance

Investors.com

Wed, 09/16/15 - 09:38 am

Tags:

Amgen, Xencor, cancer

AstraZeneca picks up discarded Amgen plant as part of its biologics expansion

Fierce Pharma

Fri, 09/11/15 - 10:48 am

Tags:

Amgen, AstraZeneca, drug manufacturing, biologics

AZ's high-powered Crestor could gain from payer limits on PCSK9 meds

Fierce Pharma Marketing

Fri, 09/11/15 - 09:55 am

Tags:

AstraZeneca, Crestor, PCSK9 inhibitors, drug pricing, Repatha, Praluent, Amgen, Regeneron, Sanofi

Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™

Yahoo

Fri, 09/11/15 - 09:50 am

Tags:

Amgen, Repatha, FDA

First 'biosimilar' drug launches in the US, years after other countries

Yahoo/AP

Thu, 09/10/15 - 06:04 pm

Tags:

biosimilars, Sandoz, Zarxio, Neupogen, Amgen

Independent group finds new cholesterol drugs far too costly

Yahoo/Reuters

Wed, 09/9/15 - 10:12 pm

Tags:

drug pricing, PCSK9 inhibitors, Praluent, Repatha, Amgen, Sanofi, Regeneron

Merck and Samsung notch their first biosimilar victory with Enbrel knockoff

Fierce Biotech

Wed, 09/9/15 - 10:42 am

Tags:

Merck, Samsung Bioepis, Enbrel, biosimilars, Amgen, rheumatoid arthritis

What’s the Market Response to Repatha’s Approval?

Yahoo/Market Realist

Tue, 09/8/15 - 08:03 am

Tags:

Repatha, Amgen, PCSK9 inhibitors

PCSK9 Inhibitor Therapies Face Pricing Pressures

Yahoo/Market Realist

Mon, 09/7/15 - 11:45 am

Tags:

PCSK9 inhibitors, drug pricing, Praluent, Repatha, Amgen, Regeneron, Sanofi

Biotech Blue-Chip Amgen Took a Drubbing Last Month -- Here's Why

Motley Fool

Mon, 09/7/15 - 11:36 am

Tags:

Amgen: Time is on My Side

Barron's

Sat, 09/5/15 - 10:56 am

Tags:

Amgen, Coherus Biosciences, FDA, Neulasta, Apotex

Pages

last 30 twitter posts